Agilent Technologies Inc. (NYSE: A) and Waters Corp. (NYSE: WAT) announced a formal agreement on June 11 to exchange instrument controls to improve the productivity of customers who own software and instruments from both companies.
This application note from Waters discusses a UPC2 method that was successfully developed to separate the three most common carotenoids in less than two minutes.
The UPC2/MS FFA analysis described here provides a simple and fast method with a significant reduction in analysis time compared to alternative techniques such as GC/MS, which requires FAME derivatization.
Learn about a flexible, universal method developed for the analysis of inter-class separations of neutral and amphipathetic lipids in this application note.
This Waters application note uses a panel of natural and synthetic opioid drugs to demonstrate the use of a systematic screening strategy for UPC2 method development.
Learn about the benefits of UPC2 in the analysis of tricyclic antidepressants in human urine.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.